Motarjemizadeh Qader, Aidenloo Naser Samadi, Abbaszadeh Mohammad
.
Glob J Health Sci. 2015 Jun 25;8(3):59-64. doi: 10.5539/gjhs.v8n3p59.
Hydroxychloroquine (HCQ) is an antimalarial drug used extensively in treatment of autoimmune diseases such as rheumatoid arthritis. Retinal toxicity is the most important side effects of this drug. Even after the drug is discontinued, retinal degeneration from HCQ can continue to progress. Consequently, multiple ophthalmic screening tests have been developed to detect early retinopathy. The aim of the current study was to evaluate the value of central 2-10 perimetry method in early detection of retinal toxicity. This prospective cross-sectional investigation was carried out on 60 rheumatoid arthritis patients, who had been receiving HCQ for at least 6 months and still were on their medication (HCQ intake) at the time of enrollment. An ophthalmologist examined participants using direct and indirect ophthalmoscopy. Visual field testing with automated perimetry technique (central 2-10 perimetry with red target) was performed on all included subjects twice in 6 months interval: The first one at the time of enrollment and the second one 6 months later. Males and females did not show any significant difference in terms of age, duration of therapy, daily and cumulative HCQ dose, anterior or posterior segment abnormalities, hypertension, body mass index, and best corrected visual acuity. Anterior segment was abnormal in 9 individuals including 3 subjects with macular pigmentary changes, 4 individuals with cataract and 2 cases with dry eyes. Moreover, 12 subjects had retinal pigmented epithelium (RPE) in their posterior segments. After 6 months, depressive changes appeared in 12 subjects. Additionally, HCQ therapy worsened significantly the perimetric results of 5 (55.6%) patients with abnormal anterior segment. A same trend was observed in perimetric results of 6 (50.0%) subjects with abnormal posterior segments (P=0.009). The daily dose of HCQ (P=0.035) as well as the cumulative dose of hydroxychloroquine (P=0.021) displayed statistically significant associations with perimetric results. Central 2-10 perimetry is a useful method for early detection of HCQ retinal toxicity, but more comprehensive studies, with larger sample size, longer-term follow-up and more precise techniques are mandatory to confirm HCQ retinal toxicity.
羟氯喹(HCQ)是一种抗疟药物,广泛用于治疗类风湿关节炎等自身免疫性疾病。视网膜毒性是该药物最重要的副作用。即使停药后,HCQ引起的视网膜变性仍可能继续进展。因此,已经开发了多种眼科筛查测试来检测早期视网膜病变。本研究的目的是评估中心2-10视野检查法在早期检测视网膜毒性中的价值。这项前瞻性横断面研究对60名类风湿关节炎患者进行,这些患者接受HCQ治疗至少6个月,且在入组时仍在服用该药物(HCQ摄入量)。一名眼科医生使用直接和间接检眼镜对参与者进行检查。对所有纳入的受试者每隔6个月使用自动视野检查技术(红色目标的中心2-10视野检查)进行两次视野测试:第一次在入组时,第二次在6个月后。男性和女性在年龄、治疗持续时间、每日和累积HCQ剂量、眼前段或后段异常、高血压、体重指数以及最佳矫正视力方面均无显著差异。9名个体眼前段异常,包括3名黄斑色素改变受试者、4名白内障患者和2名干眼症患者。此外,12名受试者后段有视网膜色素上皮(RPE)。6个月后,12名受试者出现抑郁变化。此外,HCQ治疗使5名(55.6%)眼前段异常患者的视野检查结果显著恶化。6名(50.0%)后段异常受试者的视野检查结果也观察到相同趋势(P=0.009)。HCQ的每日剂量(P=0.035)以及羟氯喹的累积剂量(P=0.021)与视野检查结果显示出统计学上的显著关联。中心2-10视野检查是早期检测HCQ视网膜毒性的一种有用方法,但需要更全面的研究,包括更大的样本量、更长时间的随访和更精确的技术来证实HCQ视网膜毒性。